MAP0004, Orally Inhaled DHE: A Randomized, Controlled Study in the Acute Treatment of Migraine

2011106 citationsJournal Article

Authors

Sheena K. Aurora · Pain and Headache Center

Stephen D. Silberstein · Mayo Clinic in Arizona

Shashidhar Kori · Pain and Headache Center

Stewart J. Tepper · Cleveland Clinic

Scott Borland · Thomas Jefferson University

Min Wang · Mayo Clinic in Arizona

David W. Dodick ·

Abstract

In this study, MAP0004 was effective and well tolerated for the acute treatment of migraine with or without aura, providing statistically significant pain relief and freedom from photophobia, phonophobia, and nausea in adults with migraine compared with placebo.

Topics & Keywords

Migraine and Headache Studies Trigeminal Neuralgia and Treatments Sympathectomy and Hyperhidrosis Treatments

Publication Details

Published in: Headache The Journal of Head and Face Pain

Volume 51, Issue 4, pp. 507-517

DOI: 10.1111/j.1526-4610.2011.01869.x

Field-Weighted Citation Impact: 8.00

Command Palette

MAP0004, Orally Inhaled DHE: A Randomized, Controlled Study in the Acute Treatment of Migraine

Authors

Abstract

Topics & Keywords

Publication Details